home / stock / sskn / sskn news

SSKN News and Press, Strata Skin Sciences Inc. From 08/09/23

Stock Information
Company Name: Strata Skin Sciences Inc.
Stock Symbol: SSKN
Market: NASDAQ
Website: strataskinsciences.com
Menu
SSKN SSKN Quote SSKN Short SSKN News SSKN Articles SSKN Message Board
Get SSKN Alerts

News, Short Squeeze, Breakout and More Instantly...
SSKN - STRATA Skin Sciences Reports Second Quarter 2023 Revenue

HORSHAM, Pa., Aug. 09, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the second quarter...
SSKN - STRATA Skin Sciences Q2 2023 Earnings Preview

2023-08-08 14:27:21 ET STRATA Skin Sciences ( NASDAQ: SSKN ) is scheduled to announce Q2 earnings results on Wednesday, August 9th, after market close. The consensus EPS Estimate is -$0.06 (-20.0% Y/Y) and the consensus Revenue Estimate is $8.74M (-4.0% Y/Y). Over the ...

SSKN - STRATA Skin Sciences to Participate in Upcoming August Conferences

HORSHAM, Pa., Aug. 01, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the company will be participating i...

SSKN - STRATA Skin Sciences to Report Second Quarter 2023 Financial Results on August 9, 2023

HORSHAM, Pa., July 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its second quar...
SSKN - STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris

HORSHAM, Pa., July 11, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the Journal of Clinical and Aesthetic ...

SSKN - STRATA Skin Sciences raises capital to refinance existing loan, takes additional $12M financing

2023-07-06 12:31:51 ET STRATA Skin Sciences ( NASDAQ: SSKN ) has entered into a new five year financing facility with MidCap Financial to refinance existing $8M term loan and an additional  $7M tranche funded at closing and also an option to receive an addition...

SSKN - STRATA Skin Sciences Secures additional $12 Million Financing with MidCap Financial

HORSHAM, Pa., July 06, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it has completed the refinancing of...
SSKN - STRATA Skin Sciences Appoints Dr. Uri Geiger to Chairman of its Board of Directors

HORSHAM, Pa., June 30, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the appointment of Dr. Uri Geiger as the...

SSKN - STRATA Skin Sciences Announces First Patients Treated in TheraClear®X Clinical Study for Acne

HORSHAM, Pa., May 30, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the first six patients have been tre...

SSKN - STRATA Skin Sciences Announces TheraClear®X Product Demonstration at Music City Scale Symposium for Cosmetic Advances and Laser Education

HORSHAM, Pa., May 19, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced Joel L. Cohen, MD (FAAD, FACMS), Director...
Previous 10 Next 10